These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 17331325

  • 1. Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein.
    Iwaki K, Sakaeda T, Kakumoto M, Nakamura T, Komoto C, Okamura N, Nishiguchi K, Shiraki T, Horinouchi M, Okumura K.
    J Pharm Pharmacol; 2006 Dec; 58(12):1617-22. PubMed ID: 17331325
    [Abstract] [Full Text] [Related]

  • 2. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME, Podila L, Ely D, Almeida I.
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [Abstract] [Full Text] [Related]

  • 3. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
    Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R.
    J Pharmacol Exp Ther; 1992 Nov; 263(2):840-5. PubMed ID: 1359120
    [Abstract] [Full Text] [Related]

  • 4. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1.
    Ito T, Yano I, Tanaka K, Inui KI.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):955-60. PubMed ID: 9262363
    [Abstract] [Full Text] [Related]

  • 5. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
    Hira A, Watanabe H, Maeda Y, Yokoo K, Sanematsu E, Fujii J, Sasaki J, Hamada A, Saito H.
    Biochem Pharmacol; 2008 Feb 15; 75(4):973-80. PubMed ID: 18054347
    [Abstract] [Full Text] [Related]

  • 6. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
    Barthomeuf C, Demeule M, Grassi J, Saidkhodjaev A, Beliveau R.
    Planta Med; 2006 Jun 15; 72(7):634-9. PubMed ID: 16739070
    [Abstract] [Full Text] [Related]

  • 7. Effects of P-glycoprotein inhibitors on transepithelial transport of cadmium in cultured renal epithelial cells, LLC-PK1 and LLC-GA5-COL 150.
    Kimura O, Endo T, Hotta Y, Sakata M.
    Toxicology; 2005 Mar 01; 208(1):123-32. PubMed ID: 15664439
    [Abstract] [Full Text] [Related]

  • 8. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
    Batrakova EV, Miller DW, Li S, Alakhov VY, Kabanov AV, Elmquist WF.
    J Pharmacol Exp Ther; 2001 Feb 01; 296(2):551-7. PubMed ID: 11160643
    [Abstract] [Full Text] [Related]

  • 9. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
    Sugimoto H, Hirabayashi H, Kimura Y, Furuta A, Amano N, Moriwaki T.
    Drug Metab Dispos; 2011 Jan 01; 39(1):8-14. PubMed ID: 20962062
    [Abstract] [Full Text] [Related]

  • 10. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K, Lan LB, Sanglard D, Furuya K, Schuetz JD, Schuetz EG.
    J Pharmacol Exp Ther; 2002 Oct 01; 303(1):323-32. PubMed ID: 12235267
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products.
    Yoshida N, Koizumi M, Adachi I, Kawakami J.
    Food Chem Toxicol; 2006 Dec 01; 44(12):2033-9. PubMed ID: 16904803
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of MDR1 in an intestinal cell line results in increased cholesterol uptake from micelles.
    Tessner TG, Stenson WF.
    Biochem Biophys Res Commun; 2000 Jan 19; 267(2):565-71. PubMed ID: 10631102
    [Abstract] [Full Text] [Related]

  • 13. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat.
    Shirasaka Y, Kuraoka E, Spahn-Langguth H, Nakanishi T, Langguth P, Tamai I.
    J Pharmacol Exp Ther; 2010 Jan 19; 332(1):181-9. PubMed ID: 19779132
    [Abstract] [Full Text] [Related]

  • 14. Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells.
    Troost J, Lindenmaier H, Haefeli WE, Weiss J.
    Mol Pharmacol; 2004 Nov 19; 66(5):1332-9. PubMed ID: 15308763
    [Abstract] [Full Text] [Related]

  • 15. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil.
    Kakumoto M, Sakaeda T, Takara K, Nakamura T, Kita T, Yagami T, Kobayashi H, Okamura N, Okumura K.
    Cancer Sci; 2003 Jan 19; 94(1):81-6. PubMed ID: 12708479
    [Abstract] [Full Text] [Related]

  • 16. MDR1 C2005T polymorphism changes substrate specificity.
    Liu L, Fan L, Peng X, Hu D, Zhou H.
    Cancer Chemother Pharmacol; 2010 Aug 19; 66(3):617-23. PubMed ID: 20309692
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
    Wang JS, Zhu HJ, Markowitz JS, Donovan JL, DeVane CL.
    Psychopharmacology (Berl); 2006 Sep 19; 187(4):415-23. PubMed ID: 16810505
    [Abstract] [Full Text] [Related]

  • 18. Several major antiepileptic drugs are substrates for human P-glycoprotein.
    Luna-Tortós C, Fedrowitz M, Löscher W.
    Neuropharmacology; 2008 Dec 19; 55(8):1364-75. PubMed ID: 18824002
    [Abstract] [Full Text] [Related]

  • 19. Outward transfer of dopamine precursor L-3,4-dihydroxyphenylalanine (L-dopa) by native and human P-glycoprotein in LLC-PK(1) and LLC-GA5 col300 renal cells.
    Soares-Da-Silva P, Serrão MP.
    J Pharmacol Exp Ther; 2000 May 19; 293(2):697-704. PubMed ID: 10773046
    [Abstract] [Full Text] [Related]

  • 20. Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function.
    Patanasethanont D, Nagai J, Yumoto R, Murakami T, Sutthanut K, Sripanidkulchai BO, Yenjai C, Takano M.
    J Pharm Sci; 2007 Jan 19; 96(1):223-33. PubMed ID: 17031860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.